Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022

Fayette Klaassen, Melanie H. Chitwood, Ted Cohen, Virginia E. Pitzer, Marcus Russi, Nicole A. Swartwood, Joshua A. Salomon, Nicolas A. Menzies
doi: https://doi.org/10.1101/2022.11.19.22282525

Article Information

doi 
https://doi.org/10.1101/2022.11.19.22282525
History 
  • November 21, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Fayette Klaassen1,*,
  2. Melanie H. Chitwood2,
  3. Ted Cohen2,
  4. Virginia E. Pitzer2,
  5. Marcus Russi2,
  6. Nicole A. Swartwood1,
  7. Joshua A. Salomon3 and
  8. Nicolas A. Menzies1
  1. 1Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston MA
  2. 2Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven CT
  3. 3Department of Health Policy, Stanford University School of Medicine, Stanford CA
  1. ↵*Corresponding author; email: klaassen.fayette{at}gmail.com
Back to top
Posted November 21, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022
Fayette Klaassen, Melanie H. Chitwood, Ted Cohen, Virginia E. Pitzer, Marcus Russi, Nicole A. Swartwood, Joshua A. Salomon, Nicolas A. Menzies
medRxiv 2022.11.19.22282525; doi: https://doi.org/10.1101/2022.11.19.22282525
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area